Fig. 5From: Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapyT1-weighted MRI in December of 2016 showing excellent subtotal tumor response following re-re-irradiation in sagittal, coronal and axial planeBack to article page